The complaint, filed by the Law Offices of Howard G. Smith, centers on a period between August 4, 2025, and July 29, 2026. Plaintiffs allege that the company misled shareholders by failing to disclose that it shared sensitive consumer health information with third-party advertising platforms. Furthermore, the suit claims the firm billed customers for prescriptions immediately after intake forms were submitted, contradicting promises that patients would first consult with medical providers to determine appropriate treatments.
In section Releases
Investors Face November Deadline in Hims & Hers Securities Fraud Suit
Investors who incurred financial losses holding Hims & Hers Health, Inc. stock now have until November 2, 2026, to file as lead plaintiffs in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s data privacy practices and its internal prescription billing protocols during the past year.
These undisclosed practices reportedly invited regulatory scrutiny and created a high likelihood of future financial penalties. According to the filing, the company’s public statements regarding its business operations lacked a reasonable basis, leaving investors misinformed about the firm’s actual legal and operational risks. Those interested in participating or seeking further information regarding their legal rights can contact Howard G. Smith’s firm in Bensalem, Pennsylvania, before the November deadline.
Comments (0)
No comments yet. Be the first!